An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients
Salomon, D.R.
Transplantation Proceedings 23(4): 2115-2118
1991
ISSN/ISBN: 0041-1345 PMID: 1871827 Document Number: 387855
Document emailed within 1 workday
Related Documents
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Radovancevic, B.; Birovljev, S.; Frazier, O.H.; Duncan, J.M.; Bennink, W.; Sweeney, M.S.; McAllister, H.A.; Burnett, C.M.; Vega, J.D.; Lonquist, J.L. 1990: Long-term follow-up of cyclosporine-treated cardiac transplant recipients Transplantation Proceedings 22(3 Suppl 1): 21-24
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Gajarski, R.J.; Smith, E.O.; Denfield, S.W.; Rosenblatt, H.M.; Kearney, D.; Frazier, O.H.; Radovancevic, B.; Price, J.K.; Kertesz, N.J.; Towbin, J.A. 1998: Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients Transplantation 65(11): 1470-1476
Chomette, G.; Auriol, M.; Beaufils, H.; Rottemburg, J.; Cabrol, C. 1986: Morphology of cyclosporine nephrotoxicity in human heart transplant recipients Journal of Heart Transplantation 5(4): 273-278
Diflo, T.; Maki, T.; Monaco, A.P. 1989: Long-term survival and tolerance in allogeneic rat small bowel transplant recipients treated with cyclosporine Transplantation Proceedings 21(1 Pt 3): 2885-2886
Hauters, P.; de Hemptinne, B.; Carlier, M.; Malaise, J.; Ottobrelli, A.; Delaby, J.; Balducci, G.; Kestens, P.J.; Otte, J.B. 1991: Long-term analysis of glomerular filtration rate and hypertension in adult liver transplant recipients treated with cyclosporine a Transplantation Proceedings 23(1 Part 2): 1458-1459
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Remberger, M.; Ringden, O.; Aschan, J.; Ljungman, P.; Lönnqvist, B.; Markling, L. 1994: Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients Transplantation Proceedings 26(3): 1829-1830
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Hernández-Infante, E.; García-Martínez, C.; Beltrán-de-la-Luz, S.; Reyes-Acevedo, R.; Romo-Franco, L.; Delgadillo-Castañeda, R.; Orozco-Loza, I.; Chew-Wong, A. 2010: Prevalence of posttransplant hypertension in pediatric kidney transplant recipients: effect on long term allograft survival Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(5): 398-405
Belitsky, P. 1985: Cyclosporine immunosuppression in cadaver kidney recipients with a remote positive crossmatch to the current donor Transplantation Proceedings 17(4): 1937-1939
Yagisawa, T.; Takahashi, K.; Teraoka, S.; Toma, H.; Agishi, T.; Ota, K. 1987: Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats Transplantation Proceedings 19(1 Part 2): 1801-1803
Takahashi, K.; Yagisawa, T.; Teraoka, S.; Tanabe, K.; Ebihara, K.; Fuchinoue, S.; Honda, H.; Toma, T.; Agishi, T.; Ota, K. 1989: Infectious diseases in 450 kidney transplant recipients treated with cyclosporine in a single center Transplantation Proceedings 21(1 Pt 2): 1563-1566
Ingsathit, A.; Sumethkul, V.; Chalermsanyakorn, P.; Jirasiritham, S. 2006: Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study Journal of the Medical Association of Thailand 89(Suppl 2): S235-S241
Van der Heyden, A.A.; van Oers, M.H.; Cornelissen, P.; Yong, S.L.; Wilmink, J.M.; Schellekens, P.T. 1988: The influence of cyclosporine a treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients Transplantation Proceedings 20(2 Suppl 2: 190-195
Hasselder, A. 1999: Renal transplant: long-term effects of immunosuppression Professional Nurse 14(11): 771-776
Sadek, S.; Medina, Jé.; Arias, M.; Sennesael, J.; Squifflet, J-Paul.; Vogt, B. 2002: Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study Transplantation 74(4): 511-517